Work

CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up

Year: 2013

Type: article

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-013-2758-9

Authors: T. Dan, S. M. Hewitt, N. Ohri, D. Ly, B. P. Soule, S. L. Smith, K. Matsuda, U. Shankavaram, M. E. Lippman, J. B. Mitchell, K. Camphausen, N. L. Simone

Institutions: Thomas Jefferson University, Sidney Kimmel Cancer Center, National Cancer Institute, University of Miami

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: Radiation Oncology Branch - Radiation Clinic, G2766465774, Modulation of Therapeutic Response, G9000143530, G985716880

OpenAlex ID: W2127964969

FWCI: 1.035

Cites: 55

Cited by: 23

Related to: 10